LIGAND PHARMACEUTICALS INC's ticker is LGND and the CUSIP is 53220K504. A total of 3 filers reported holding LIGAND PHARMACEUTICALS INC in Q4 2023. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,323 | +50.0% | 22,082 | +80.5% | 0.09% | +51.7% |
| Q2 2023 | $882 | +42.7% | 12,237 | +45.7% | 0.06% | +20.8% |
| Q1 2023 | $618 | -99.9% | 8,400 | +147.1% | 0.05% | -61.6% |
| Q3 2018 | $933,000 | +32.5% | 3,400 | 0.0% | 0.12% | +17.9% |
| Q2 2018 | $704,000 | +25.3% | 3,400 | 0.0% | 0.11% | +19.1% |
| Q1 2018 | $562,000 | – | 3,400 | – | 0.09% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BVF INC/IL | 2,626,160 | $138,136,000 | 24.17% |
| KNOTT DAVID M | 1,292,566 | $67,988,972,000 | 13.87% |
| GROW Partners, LLC | 200,000 | $10,520,000 | 6.41% |
| Opaleye Management Inc. | 90,000 | $4,860,000,000 | 3.82% |
| OBERWEIS ASSET MANAGEMENT INC/ | 213,317 | $11,220,000 | 2.72% |
| First Light Asset Management, LLC | 60,242 | $3,169,000 | 2.69% |
| Timpani Capital Management LLC | 98,956 | $5,205,000 | 2.59% |
| Iguana Healthcare Management, LLC | 75,000 | $3,945,000 | 2.25% |
| Eventide Asset Management | 134,400 | $7,069,000 | 2.18% |
| ASHFORD CAPITAL MANAGEMENT INC | 215,223 | $11,321,000 | 2.16% |